Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
复制标题
DOI：
10.1186/s13195-021-00868-7
复制
发表时间：
2021-07-08
期刊：
影响因子：
--
通讯作者：
Graham T
中科院分区：
文献类型：
--
作者：
Goldman JG;Boeve BF;Armstrong MJ;Galasko DR;Galvin JE;Irwin DJ;Leverenz JB;Marder K;Abler V;Biglan K;Irizarry MC;Keller B;Lai R;Munsie L;Belleville M;Chaney O;Richard I;Taylor A;Graham T
2019年，路易体痴呆协会成立了一个行业咨询委员会，将一个利益相关者合作小组聚集在一起，目标是加速路易体痴呆治疗的临床研究。在2020年6月18日举行的第二届行业咨询委员会年会上，主要成员介绍了为实现委员会目标所做的持续和计划的努力。会议还讨论了COVID-19大流行对路易体痴呆临床研究的影响，从中吸取的经验教训，以及如何将这些经验教训应用于未来临床试验的设计和实施。本报告提供了会议记录的简要总结，重点是改进和适应未来路易体痴呆临床研究的努力。
In 2019, the Lewy Body Dementia Association formed an Industry Advisory Council to bring together a collaborative group of stakeholders with the goal of accelerating clinical research into Lewy body dementia treatments. At the second annual meeting of the Industry Advisory Council, held virtually on June 18, 2020, the key members presented ongoing and planned efforts toward the council’s goals. The meeting also featured a discussion about the effects of the COVID-19 pandemic on Lewy body dementia clinical research, lessons learned from that experience, and how those lessons can be applied to the design and conduct of future clinical trials. This report provides a brief summary of the meeting proceedings with a focus on efforts to improve and adapt future Lewy body dementia clinical research.
DOI：
10.1186/s13195-020-00703-5
发表时间：
2020-10-29
期刊：
Alzheimer's research & therapy
影响因子：
--
作者：
Goldman JG;Forsberg LK;Boeve BF;Armstrong MJ;Irwin DJ;Ferman TJ;Galasko D;Galvin JE;Kaufer D;Leverenz J;Lippa CF;Marder K;Abler V;Biglan K;Irizarry M;Keller B;Munsie L;Nakagawa M;Taylor A;Graham T
通讯作者：
Graham T